Rosemary Njogu’s Post

https://lnkd.in/dQCxCPFZ VACCINATION IS AN INVESTMENT NOT A COST!!! Vaccines are among the most cost-effective strategies to promote public health, preventing infectious diseases and associated morbidity, mortality, and disability. The Italian pediatric NIP brings large-scale prevention of disease-related morbidity, mortality, and associated costs over the lifetime with a positive return on investment for the national health system and for society. This highlights the value of continued investment in pediatric immunization and the importance of sustained population-level vaccination coverage to maintain the positive public health and economic impact of the NIP.

#ICYMI: Federal health officials have recommended an updated dosing schedule for the Bexsero meningococcal B (MenB) vaccine. Yesterday, the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) unanimously voted to update Bexsero's dosing schedule to match that of Trumenba – a recommendation that gets us one step closer to more streamlined meningococcal vaccine recommendations! Key Takeaways: ▪️ This change is based on new immunogenicity data. ▪️ This recommendation would mean a longer period (six months versus the current one month) between doses for healthy adolescents and young adults. ▪️ A three-dose series (instead of two) was recommended for certain high-risk populations administered at 0, 1-2 months, and 6 months. MenB vaccines are still not interchangeable. ▪️ This recommendation is not considered final until it is published in the CDC Morbidity and Mortality Weekly Report. We remain optimistic that more enhancements and harmonization to the meningococcal vaccine recommendations in the U.S. are on the horizon for 2025. Read more on this topic from this latest article from the American Academy of Pediatrics: https://lnkd.in/eBzfSm-f.

Congratulations to our colleague An Ta Kakouriotis, PhD, SFHEA for her recent publication together with Pfizer in Human Vaccine and Immunotherapeutics! In September 2023, 10-valent pneumococcal conjugate vaccine (PCV) was replaced by 15-valent PCV (PCV15) in Sweden’s pediatric national immunization program. Following European approval of 20-valent PCV (PCV20) in March 2024, we assessed the cost-effectiveness of PCV20 versus PCV15, both under 2 + 1 schedule, among Sweden’s pediatric population. A Markov state-transition model evaluated the economic and health benefits of PCV20 versus PCV15 among all ages over a 10-year time horizon. Read the full article here: https://hubs.ly/Q02QV21k0

In this brief video interview, Tina Tan, MD, FAAP, FIDSA, FPIDS, discusses the recent trend of increased vaccine exemptions, and highlights the importance of #vaccination coverage in the pediatric population. We also highlight recent data from the #CDC regarding coverage and exemptions. Watch here: https://lnkd.in/ettH8KaW

Vaccines are recommended for adults based on age, health conditions, job, and other factors. Use Centers for Disease Control and Prevention's Adult Vaccine Assessment Tool to find out which vaccinations you need: https://lnkd.in/eFaZtZ2 #NationalImmunizationAwarenessMonth #IVax2Protect

3 immunization strategies are currently available for protecting against #RSV disease in young children, #pregnant women, and in older adults. These are passive immunization of young children, active immunization of pregnant women to protect new born babies, and active immunization of older adults. It is now time to assess how these startagies perform beyond their demonstrated clinical efficacy i.e., in the #realworld. However, the set up and interpretation of effectiveness studies needs careful considerations. https://lnkd.in/egChCVKN

Protecting Our Future: The Vital Role of Vaccines in Pediatric Health As a pediatric nurse, I've witnessed firsthand the profound impact of vaccines in safeguarding children's health. Vaccinations are not just shots; they are shields that protect our little ones from serious diseases and their devastating consequences. 🌟 Preventing Disease: Vaccines are our frontline defense against diseases like measles, polio, and whooping cough. They help prevent outbreaks and protect vulnerable members of our community. 👶 Ensuring Healthy Growth: By immunizing children early in life, we ensure they can grow and thrive without the threat of debilitating illnesses that can derail their development. 💪 Boosting Immunity: Vaccines strengthen a child's immune system, preparing it to fight off infections effectively. This not only protects them but also contributes to community immunity (herd immunity), reducing the spread of diseases. 📈 Supporting Evidence-Based Medicine: The safety and effectiveness of vaccines are supported by extensive research and rigorous testing. They are one of the most successful public health interventions in history. 🌍 Global Impact: Vaccines are essential globally, bridging gaps in health disparities and saving millions of lives each year across the world. As caregivers, parents, and healthcare professionals, it's our responsibility to advocate for vaccination. Let's ensure every child has access to lifesaving immunizations. Together, we can protect our future generation. #VaccinesSaveLives #PediatricHealth #PublicHealth #ChildhoodImmunizations #NurseLife #HealthcareAdvocacy

In this brief video interview, Tina Tan, MD, FAAP, FIDSA, FPIDS, discusses the recent trend of increased vaccine exemptions, and highlights the importance of #vaccination coverage in the pediatric population. We also highlight recent data from the #CDC regarding coverage and exemptions. Watch here: https://lnkd.in/ettH8KaW

In this brief video interview, Tina Tan, MD, FAAP, FIDSA, FPIDS, discusses the recent trend of increased vaccine exemptions, and highlights the importance of #vaccination coverage in the pediatric population. We also highlight recent data from the #CDC regarding coverage and exemptions. Watch here: https://lnkd.in/ettH8KaW

🌟 Exciting News! 🌟 I am thrilled to announce that our latest study has been published in the BMJ! 📚 Study Title: Covid-19 infection and vaccination during first trimester and risk of congenital anomalies: Nordic registry based study. In this research, we utilized comprehensive register data from Norway, Sweden, and Denmark to investigate the potential impact of COVID-19 infection and COVID-19 vaccination on congenital anomalies. 🧬 Key Finding: We found no association between COVID-19 infection or COVID-19 vaccination and congenital anomalies! Read more here: 🔗 https://lnkd.in/djs9K4Pb #Research #COVID19 #Vaccination #CongenitalAnomalies #Healthcare #BMJ #PublicHealth #Norway #Sweden #Denmark #Science